Guided Therapeutics (GTHP) Operating Margin (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 68,799.00 |
| Sep 30, 2025 | -15,620.00 |
| Mar 31, 2024 | -446,771.00 |
| Jun 30, 2023 | 41,136.00 |
| Sep 30, 2022 | -2.65 Mn |
| Jun 30, 2022 | -548,000.00 |
| Mar 31, 2022 | -813,500.00 |
| Dec 31, 2021 | 183,816.00 |
| Sep 30, 2021 | 2.55 Mn |
| Dec 31, 2020 | -95,330.00 |
| Dec 31, 2019 | 1.78 Mn |
| Sep 30, 2019 | 1.39 Mn |
| Jun 30, 2019 | -3.13 Mn |
| Mar 31, 2019 | -35,873.00 |
| Dec 31, 2018 | 1.06 Mn |
| Sep 30, 2018 | -556,250.00 |
| Jun 30, 2018 | 326,250.00 |
| Mar 31, 2018 | -871,682.00 |
| Dec 31, 2017 | 337,440.00 |
| Sep 30, 2017 | -344,493.00 |
| Jun 30, 2017 | 183,498.00 |
| Mar 31, 2017 | -267,684.00 |
| Dec 31, 2016 | 94,395.00 |
| Dec 31, 2015 | 581,944.00 |
| Sep 30, 2015 | -696,500.00 |
| Jun 30, 2015 | -609,000.00 |
| Mar 31, 2015 | 661,077.00 |
| Dec 31, 2014 | -555,350.00 |
| Sep 30, 2014 | 745,000.00 |
| Jun 30, 2014 | -748,517.00 |
| Mar 31, 2014 | -1.06 Mn |
| Dec 31, 2013 | 151,680.00 |
| Sep 30, 2013 | -112,274.00 |
| Jun 30, 2013 | 33,852.00 |
| Mar 31, 2013 | -100,744.00 |
| Dec 31, 2012 | 2,465.00 |
| Sep 30, 2012 | -1,451.00 |
| Jun 30, 2012 | 1,325.00 |
| Mar 31, 2012 | 18,293.00 |
| Dec 31, 2011 | -6,220.00 |
| Sep 30, 2011 | -20,633.00 |
| Jun 30, 2011 | 4,336.00 |